Review article: faecal transplantation therapy for gastrointestinal disease
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractSummary Background Evidence is emerging regarding the relationship between a dysbiosis of the human gut microbiota and a number of gastrointestinal diseases as well as diseases beyond the gut. Probiotics have been investigated in many gastrointestinal disease states, with variable and often modest outcomes. Faecal transplantation is an alternative approach to manipulate the gut microbiota. Aim To review the use of faecal transplantation therapy for the management of gastrointestinal disorders. Methods Available articles on faecal transplantation in the management of gastrointestinal disorders were identified using a Pubmed search and bibliographies of review articles on the subject were collated. Results A total of 239 patients who had undergone faecal transplantation were reported. Seventeen of 22 studies of faecal transplantation were in fulminant or refractory Clostridium difficile. Studies of faecal transplantation are heterogeneous regarding the patients, donors, screening, methods of administration and definition of response. Faecal transplantation for C. difficile has been demonstrated to be effective in 145/166 (87%) patients. Small numbers of patients are reported to have undergone successful faecal transplantation for irritable bowel syndrome and inflammatory bowel disease. Conclusions Faecal transplantation has been reported with good outcomes for fulminant and refractory C. difficile. No adverse effects of faecal transplantation have been reported. However, there are no level 1 data of faecal transplantation and reports to date may suffer from reporting bias of positive outcomes and under-reporting of adverse effects. This therapy holds great promise, where a dysbiosis of the gut microbiota is responsible for disease and further studies are necessary to explore this potential.
CitationLandy, J., Al-Hassi, H.O., Mclaughlin, S.D., Walker, A.W., Ciclitira, P., Nicholls, R.J., Clark, S.K. and Hart, A.L. (2011) Review article: faecal transplantation therapy for gastrointestinal disease.. Alimentary Pharmacology and Therapeutics, Wiley, 2011, 34 (4), pp.409. ff10.1111/j.1365-2036.2011.04737.x
JournalAlimentary Pharmacology and Therapeutics
PubMed ID21682755 (pubmed)
DescriptionThis is an accepted manuscript of an article published by Wiley in Alimentary Pharmacology and Therapeutics on 20/06/2011, available online: https://doi.org/10.1111/j.1365-2036.2011.04737.x The accepted version of the publication may differ from the final published version.
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/
- Review article: faecal transplantation therapy for gastrointestinal disease.
- Authors: Landy J, Al-Hassi HO, McLaughlin SD, Walker AW, Ciclitira PJ, Nicholls RJ, Clark SK, Hart AL
- Issue date: 2011 Aug
- Prebiotic effects: metabolic and health benefits.
- Authors: Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco MJ, Léotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, Meheust A
- Issue date: 2010 Aug
- Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.
- Authors: Chassard C, Dapoigny M, Scott KP, Crouzet L, Del'homme C, Marquet P, Martin JC, Pickering G, Ardid D, Eschalier A, Dubray C, Flint HJ, Bernalier-Donadille A
- Issue date: 2012 Apr
- The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?
- Authors: Damman CJ, Miller SI, Surawicz CM, Zisman TL
- Issue date: 2012 Oct